跳至主要内容
临床试验/NCT00489866
NCT00489866已完成2 期

Aripiprazole Augmentation of Antidepressants in PTSD

Durham VA Medical Center1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2007年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
14
试验地点
1
主要终点
Clinician Administered PTSD Scale (CAPS)

研究概览

简要总结

The proposed investigation will determine the therapeutic potential of aripiprazole augmentation to a stable antidepressant regimen for reducing posttraumatic stress disorder (PTSD) symptoms, cognitive symptoms, psychotic symptoms, and depressive symptoms in veterans with PTSD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Outpatient veterans with posttraumatic stress disorder (PTSD)
  • Receiving treatment with an antidepressant at a stable dose for 4 weeks
  • Male or female
  • Ages 18-65 years old

排除标准

  • 未提供

研究组 & 干预措施

Aripiprazole

Experimental

干预措施: Aripiprazole (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Clinician Administered PTSD Scale (CAPS)

时间窗: Week 2 and Week 6

Mean change scores (Week 2 minus Week 6) in posttraumatic stress disorder symptoms. Scores may range from 0 (no symptoms) to 136 (severe symptoms; score of 136 is based on the first 17 CAPS items administered). A reduced CAPS score indicates a reduction in (improvement) PTSD symptoms, while an increase in CAPS score indicates an increase (worsening) in PTSD symptoms.

Brief Assessment of Cognition in Affective Disorders (BAC-A)

时间窗: Week 2 and Week 6

The BACS includes brief assessments of executive functions, verbal fluency, attention, verbal memory, working memory and motor speed. Z-scores are calculated from composite scores. Higher z-scores are indicative of better cognitive performance, lower z-scores are indicative of lower cognitive performance. Range of z-scores anticipated to be between -3 and 3. Mean change scores from week 2 and week 6 (Week 2 minus Week 6).

Positive and Negative Symptoms Scale (PANSS)

时间窗: Week 2 and Week 6

The PANSS is a widely used measure with several subdomains, including positive symptoms, negative symptoms, and general psychopathology of schizophrenia. Lower scores are indicative of fewer symptoms; higher scores are indicative of more symptoms. Total PANSS scores range from 0-20.Mean change scores from Week 2 and Week 6 (Week 2 minus Week 6)

次要结局

  • Connor-Davidson Resilience Scale (CD-RISC)(Week 2 and Week 6)
  • Beck Depression Inventory, Second Edition (BDI-II)(Week 2 and Week 6)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验